Star Sports Medicine Co., Ltd. - H Shares Stock: price and insider trades · Hong Kong
1 insider bought €1.5M of shares over the last 90 days, the latest by DONG WENXING, filed 04 Nov 2026.
Star Sports Medicine Co., Ltd. - H Shares: what insiders have been doing
Star Sports Medicine Co., Ltd. - H Shares is a listed company. Filings by its managers are published through HKEX. 1 insider has disclosed 22 filings since 4 November 2025.
No insider sold shares on the market over the period. Instead, the filings list 22 purchases totalling €1.5M, made by 1 insider. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 senior executive among the declarants. At €170k, the purchase published on 28 October 2026 by Dong Wenxing is the largest of the period.
The most recent open-market purchase was published on 4 November 2026, 4 days ago. Filings reach the HKEX feed a median of 2 days after the trade. Until a filing is published, the market cannot know about the trade.
Across the 1,325 companies tracked on its exchange, the median is 4 filings; at 22 filings, this issuer sits above that mark. Looking back to 2026, when coverage begins, insiders filed 22 purchases and no sales.
Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 8,000 shares@ HK$51.4703ShareXHKGHKEX:DA20261104E00258Canonical exit: 28 Jan 2027 (T+90)
- 10,000 shares@ HK$48.3926ShareXHKGHKEX:DA20261104E00257Canonical exit: 1 Feb 2027 (T+90)
- 10,000 shares@ HK$51.2334ShareXHKGHKEX:DA20261104E00256Canonical exit: 31 Jan 2027 (T+90)
- 17,000 shares@ HK$54.17827.8% of flowShareXHKGHKEX:DA20261029E00388Canonical exit: 26 Jan 2027 (T+90)
- 8,000 shares@ HK$53.76193.6% of flowShareXHKGHKEX:DA20261029E00387Canonical exit: 25 Jan 2027 (T+90)
- 8,000 shares@ HK$53.33754.1% of flowShareXHKGHKEX:DA20261027E00557Canonical exit: 24 Jan 2027 (T+90)
- 30,000 shares@ HK$49.88614.3% of flowShareXHKGHKEX:DA20261027E00556Canonical exit: 21 Jan 2027 (T+90)
- 26,200 shares@ HK$50.454715.4% of flowShareXHKGHKEX:DA20261023E00211Canonical exit: 20 Jan 2027 (T+90)
- 8,400 shares@ HK$54.18245.3% of flowShareXHKGHKEX:DA20261022E00528Canonical exit: 19 Jan 2027 (T+90)
- 16,850 shares@ HK$60.445311.9% of flowShareXHKGHKEX:DA20261022E00527Canonical exit: 18 Jan 2027 (T+90)
- 2,500 shares@ HK$67.3232.9% of flowShareXHKGHKEX:DA20261020E00089Canonical exit: 14 Jan 2027 (T+90)
- 2,500 shares@ HK$66.502.9% of flowShareXHKGHKEX:DA20261020E00088Canonical exit: 12 Jan 2027 (T+90)
- 2,500 shares@ HK$62.0952.9% of flowShareXHKGHKEX:DA20261014E00080Canonical exit: 11 Jan 2027 (T+90)
- 2,000 shares@ HK$63.04882.4% of flowShareXHKGHKEX:DA20261013E00476Canonical exit: 10 Jan 2027 (T+90)
- 2,500 shares@ HK$63.093.0% of flowShareXHKGHKEX:DA20261013E00475Canonical exit: 7 Jan 2027 (T+90)
- 5,000 shares@ HK$69.25256.9% of flowShareXHKGHKEX:DA20261009E00228Canonical exit: 6 Jan 2027 (T+90)
- 2,950 shares@ HK$75.91954.5% of flowShareXHKGHKEX:DA20261009E00227Canonical exit: 5 Jan 2027 (T+90)
- 13,000 shares@ HK$77.396922.5% of flowShareXHKGHKEX:DA20261006E00055Canonical exit: 29 Dec 2026 (T+90)
- 2,550 shares@ HK$79.73044.6% of flowShareXHKGHKEX:DA20261006E00057Canonical exit: 31 Dec 2026 (T+90)
- 7,100 shares@ HK$111.868323.8% of flowShareXHKGHKEX:DA20260911E00113Canonical exit: 9 Dec 2026 (T+90)
- 11,000 shares@ HK$115.7838.1% of flowShareXHKGHKEX:DA20260911E00073Canonical exit: 8 Dec 2026 (T+90)
- 10,600 shares@ HK$120.24138.1% of flowShareXHKGHKEX:DA20260910E00020Canonical exit: 7 Dec 2026 (T+90)
22 of 22 declarations
About Star Sports Medicine Co., Ltd. - H Shares
Star Sports Medicine Co., Ltd. is a company focused on the manufacturing and distribution of sports-related medical products. It is publicly traded under the H Shares category.